CaverStem® is Rooted in Science
CaverStem® is the only patented and clinically tested stem cell based treatment for erectile dysfunction. It was developed by Creative Medical Technology Holdings, Inc., a biotechnology company committed to improving patient lives in the areas of Urology, Neurology, and Orthopedics. CaverStem® is the direct result of research, collaboration, and clinical testing between some of the preeminent physicians and scientists in the world who specialize in erectile dysfunction and stem cell therapy.
Through our clinical trial with University of California Los Angeles (UCLA), we have methodically tested and proven that the CaverStem® procedure is both safe and extremely effective. In fact from an efficacy standpoint, CaverStem® is far superior in helping patients regain their sexual function long term compared to any other ED treatments. This is seen across the patient spectrum, for individuals who no longer or have never responded positively to PED5 inhibitors (such as Cialis and Viagra), for those who have had a prostatectomy, for those who have various levels of ED, and even for patients who are just looking to regain the same function and performance they have slowly lost over time.
CaverStem® has both the pedigree of being developed by leaders in the field of stem cell treatments and the proven long-lasting efficacy to stand apart from other less effective ED treatments such as Gainswave®, shockwave therapy, and platelet rich plasma (P-Shot®). It also is the only stem cell based treatment for ED that falls within the FDA’s guidelines for stem cell treatments and specifically exception 21 CFR 1271.15(b). This FDA guidance allows for removing and implanting “human cells, tissues, and cellular or tissue-based products” (HCT/Ps) into the same individual from whom they were removed (autologous use) and implanting the HCT/Ps within the same surgical procedure, However to be compliant, the HCT/Ps must remain in their original form, which means that they are only rinsed, cleaned, sized, or shaped in the procedure. CaverStem® meets all of these requirements via our patented protocol utilizing autologous bone marrow derived stem cells. Stem cell treatments offered by other practitioners utilizing adipose, cord, and amnionic derived stem cells do not meet this exception due to manipulation of cells and/or the cells not originating in the patient being treated. Therefore CaverStem® is also the only patented and FDA compliant stem cell treatment for ED.
Our Scientific & Medical Experts
Thomas Ichim PhD
20+ year veteran in the biotechnology industry. Former President and Chief Scientific Officer at Medistem, Inc. Co-Founder Creative Medical Technology Holdings Inc. Co- Inventor CaverStem Technology and other technologies in our portfolio.
Alex Gershman MD
Formerly with UCLA as Assistant Professor, Dept. of Urology, Director of Urologic Laparoscopy, Harbor-UCLA Medical Center, Head of Endourology Division, Dept. of Surgery, V.A. West L.A. Medical Center. Scientific Advisory Board Member and first physician to perform the CaverStem procedure commercially.
Timothy Henry MD
Director of Cardiology, Cedars-Sinai Heart Institute. Dr. Henry’s experience also includes Director of Research at Minneapolis Heart Institute Foundation.
Eric Duckers MD PhD
Assistant Professor, Erasmus Medical Center, Head, Molecular Cardiology Laboratory, Erasmus Medical Center and Interventional Cardiologist, Erasmus Medical Center, Rotterdam, Netherlands.
Amit Patel MS MD
Cardiac surgeon, former Associate Professor and Director of Clinical Regenerative Medicine and Tissue Engineering at the University of Utah. Dr. Patel has pioneered break-through therapies using stem cells and is a recognized world leader in stem cell therapies. Co – Founder Creative Medical Technology Holdings, Inc. Co-Inventor of our technologies.